Penile Squamous Cell Carcinoma: Clinical Trials

2 trials for Penile Squamous Cell Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Unknown 2

Follow Penile Squamous Cell Carcinoma: new trials by email Literature Review of Penile Squamous Cell Carcinoma trials Research Report on Penile Squamous Cell Carcinoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cabozantinib in Patients With Advanced Penile Squamous Cell Carcinoma (PSCC) (CaboPen)
Cabozantinib - Penile Squamous Cell Carcinoma
Phase 2UnknownFondazione IRCCS Istituto Nazionale dei Tumori, Milano372019-08-012021-02-25
Maintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile Carcinoma
Avelumab - Penile Cancer, Penile Neoplasms
Phase 2UnknownCentre Hospitalier Universitaire de Besancon322019-03-122023-04-21

Narrower conditions

Penile Neoplasms (1)

Broader conditions

Genital Diseases (1)  ·  Genital Diseases, Male (1)  ·  Genital Neoplasms, Male (1)  ·  Male Urogenital Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Penile Diseases (1)  ·  Urogenital Diseases (1)  ·  Urogenital Neoplasms (1)

Interventions

avelumab (1)  ·  cabozantinib (1)

Sponsors

Centre Hospitalier Universitaire de Besancon (1)  ·  Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1)

Countries

France (1)  ·  Italy (1)

Top investigators

Daniele Raggi, MD (1)

Results publications

PMID 32620211

NIH funding

2018 (1)